Showing results (1-10 of 533) with videos related to
Sort By:
Pageof 54
Breast Cancer Research and Treatment|January 1, 1994
Second generation aromatase inhibitor--4-hydroxyandrostenedioneM Dowsett, R C CoombesThe Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patientsM Dowsett, R C Stein, R C CoombesEndocrine-Related Cancer|March 24, 2000
Aromatase inhibitors and their use in the sequential settingR C Coombes, C Harper-Wynne, M DowsettEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1992
4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancerR C Coombes, S W Hughes, M DowsettJournal of Steroid Biochemistry|January 1, 1987
Aromatase inhibitors: basic and clinical studiesA M Brodie, R C Coombes, M DowsettClinical Endocrinology|May 1, 1990
Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patientsM Dowsett, R C Stein, A Mehta, et al.Lancet (London, England)|December 1, 1984
4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancerR C Coombes, P Goss, M Dowsett, et al.Journal of Steroid Biochemistry|November 1, 1986
Aromatase inhibitors and their potential clinical significanceA M Brodie, L Y Wing, P Goss, et al.Breast Cancer Research and Treatment|October 12, 1999
Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancerM Dowsett, D Doody, S Miall, et al.Journal of Steroid Biochemistry|January 1, 1986
Aromatase inhibitors and the treatment of breast cancerA M Brodie, L Y Wing, P Goss, et al.Pageof 54